Lyra Therapeutics, Inc.
LYRA
Revenue
25.00k
▼-158.00k▼-86.34%
3 Months ChangeAssets
43.71M
▼-8.86M▼-16.86%
3 Months ChangeLiabilities
48.04M
▼-2.91M▼-5.72%
3 Months ChangeFree Cash Flow
-24.60M
▼-8.71M▼-54.79%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-14
Form 10-Q
ID: 0000950170-24-097042
2024-08-14
Form 8-K
ID: 0000950170-24-097007
2024-07-23
Form 8-K
ID: 0001193125-24-182860
2024-06-18
Form 8-K
ID: 0001193125-24-163395
2024-05-21
Form 8-K
ID: 0001193125-24-143419
2024-04-30
Form 10-Q
ID: 0000950170-24-050535
2024-04-30
Form 8-K
ID: 0000950170-24-050525
2024-04-19
Form 8-K
ID: 0001193125-24-102914
2024-03-21
Form 8-K
ID: 0000950170-24-034701
2024-03-01
Form 8-K
ID: 0000950170-24-023918